Charles Schwab Investment Management »

Silverback Therapeutics shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in Silverback Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Silverback Therapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silverback Therapeutics by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.8M 330k 5.48
2023-09-30 $1.2M 324k 3.78
2023-06-30 $480k 72k 6.70
2023-03-31 $105k 16k 6.51
2022-12-31 $138k 16k 8.53
2022-06-30 $452k 106k 4.25
2022-03-31 $518k 147k 3.51
2021-12-31 $992k 149k 6.66
2021-09-30 $1.4M 139k 9.99
2021-06-30 $2.7M 86k 30.90
2021-03-31 $3.7M 84k 43.63